Stevens First Principles Investment Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $1.58M | Sell |
31,660
-680
| -2% | -$34K | 0.92% | 33 |
|
|
2019
Q1 | $1.69M | Sell |
32,340
-2,294
| -7% | -$120K | 1.01% | 32 |
|
|
2018
Q4 | $1.65M | Buy |
34,634
+720
| +2% | +$34.4K | 1.12% | 30 |
|
|
2018
Q3 | $1.7M | Buy |
33,914
+1,144
| +3% | +$57.4K | 0.98% | 33 |
|
|
2018
Q2 | $1.65M | Sell |
32,770
-24
| -0.1% | -$1.21K | 1% | 33 |
|
|
2018
Q1 | $1.6M | Sell |
32,794
-134
| -0.4% | -$6.55K | 0.98% | 33 |
|
|
2017
Q4 | $1.46M | Buy |
32,928
+498
| +2% | +$22.1K | 0.79% | 40 |
|
|
2017
Q3 | $1.65M | Buy |
32,430
+1,428
| +5% | +$72.5K | 0.9% | 37 |
|
|
2017
Q2 | $1.67M | Sell |
31,002
-208
| -0.7% | -$11.2K | 0.99% | 38 |
|
|
2017
Q1 | $1.65M | Buy |
31,210
+452
| +1% | +$23.8K | 1.05% | 36 |
|
|
2016
Q4 | $1.48M | Buy |
30,758
+980
| +3% | +$47.2K | 1.03% | 35 |
|
|
2016
Q3 | $1.61M | Sell |
29,778
-192
| -0.6% | -$10.3K | 1.16% | 32 |
|
|
2016
Q2 | $1.62M | Sell |
29,970
-816
| -3% | -$44.2K | 1.21% | 31 |
|
|
2016
Q1 | $1.56M | Sell |
30,786
-30
| -0.1% | -$1.52K | 1.26% | 28 |
|
|
2015
Q4 | $1.55M | Sell |
30,816
-2,244
| -7% | -$113K | 1.32% | 29 |
|
|
2015
Q3 | $1.59M | Sell |
33,060
-48
| -0.1% | -$2.31K | 1.27% | 30 |
|
|
2015
Q2 | $1.72M | Buy |
33,108
+2,148
| +7% | +$112K | 1.12% | 34 |
|
|
2015
Q1 | $1.79M | Buy |
30,960
+1,216
| +4% | +$70.1K | 1.15% | 33 |
|
|
2014
Q4 | $1.59M | Buy |
29,744
+1,788
| +6% | +$95.5K | 1.05% | 36 |
|
|
2014
Q3 | $1.61M | Buy |
27,956
+4,688
| +20% | +$269K | 0.9% | 42 |
|
|
2014
Q2 | $1.56M | Sell |
23,268
-80
| -0.3% | -$5.35K | 0.85% | 43 |
|
|
2014
Q1 | $1.56M | Buy |
23,348
+3,440
| +17% | +$230K | 1.01% | 36 |
|
|
2013
Q4 | $1.33M | Hold |
19,908
| – | – | 0.79% | 45 |
|
|
2013
Q3 | $1.25M | Buy |
19,908
+4,004
| +25% | +$251K | 0.74% | 48 |
|
|
2013
Q2 | $993K | Buy |
+15,904
| New | +$993K | 0.7% | 49 |
|